Revolution Medicines, Inc.

NASDAQ:RVMD

44.42 (USD) • At close January 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -436.367-248.705-187.091-108.159-47.664-41.789-31.127
Depreciation & Amortization 9.3099.6567.3326.5453.3421.7641.188
Deferred Income Tax -3.91-0.4190-0.375-4.3730.2010
Stock Based Compensation 61.77231.19620.7248.8863.1610.8550.141
Change In Working Capital 36.752-13.4898.724-8.304-8.82838.0614.65
Accounts Receivables 3.4191.2560.4642.344-1.434-7.3030
Inventory 007.682-2.3441.43400
Accounts Payables 32.4697.2882.2390.3055.2640.1091.968
Other Working Capital 0.864-22.033-1.661-8.609-14.09237.9522.682
Other Non Cash Items -18.128-2.643.1311.3434.7462.1210.549
Operating Cash Flow -350.572-224.401-147.18-100.064-49.6161.213-25.148
Investing Activities:
Investments In Property Plant And Equipment -7.729-10.816-6.528-2.933-2.589-1.499-1.575
Acquisitions Net 013.3135.589231.30.1960.160
Purchases Of Investments -1,058.916-612.769-671.335-544.133-172.26600
Sales Maturities Of Investments 724.047599.469535.746312.83366.6900
Other Investing Activites -0-13.3-135.589-231.3600
Investing Cash Flow -342.598-24.116-142.117-234.233-101.969-1.339-1.575
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 385.759298.045291.241420.067100.0280.420.074
Common Stock Repurchased 3.317000-0.045-0.1310
Dividends Paid 0000000
Other Financing Activities 843.4413.3872.9382.70998.65860.84745.25
Financing Cash Flow 1,229.2301.432294.179422.77698.65860.84722.662
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash 536.0352.9154.88288.479-52.92760.721-4.061
Cash At End Of Period 699.179163.149110.234105.35216.87369.89.079